Defiance Daily Target 2X Long MRNA ETF (MRNX)

MRNX, as a leveraged ETF tracking Moderna, has shown a volatile price pattern over the last 14 days, with significant swings and a recent dip to the current price of $26.29. The lack of recent dividends makes it unsuitable for income-focused investors. The forecasting model lacks statistical reliability, suggesting limited predictive power for short-term movements. While the recent dip could present a buying opportunity for short-term traders looking to capitalize on momentum, the overall volatility and uncertain fundamentals suggest caution. Long-term investors should avoid this ETF due to its lack of sustainable fundamentals and the inherent risks associated with leveraged products.